Göteborg University
Gothenburg, 41345, Sweden
NCT Number: NCT03466593
Open upper gastrointestinal surgery includes surgery in the upper abdomen such as ventricular, duodenal, pancreatic and biliary tract surgery. After upper abdominal surgery there is a risk of gastrointestinal and cardiopulmonary complications. There is currently insufficient knowledge about the effect of prehabilitation and extra early postoperative mobilization in upper pancreatic surgery.
This study's aim is to evaluate the effect of prehabilitation and extra early mobilization.
The study includes two substudies:
1. A prospective cohort of 75 patients undergoing pancreatic surgery after a prehabilitation program will be compared to 75 historical controls. Primary outcome is postoperative complications. 2. A randomized controlled trial based on 72 patients undergoing pancreatic studying the effect of extra early rehabilitation. The intervention group will be mobilized to bedside, standing or sitting in armchair <6 hours after surgery, ie 3-4 hours after arrival at the Postoperative Department (PIVA). The control group will be mobilized according to routine i.e. the morning after surgery. Primary outcome is PaO2.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Gothenburg, 41345, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
in substudy b:
Prehabilitation concerning eating, smoking, drinking and physical activity
Preoperative information
Mobilization the day of surgery
Mobilization the day after surgery
Time frame: Whole study period from inclusion to one year after surgery
Standardized complications according to register
Time frame: The day before surgery to the first day after surgery
Arterial oxygen pressure
Time frame: Whole study period from inclusion to one year after surgery
Quality of life, EORTC-QLQ-C30 (Range 30-124) Low values correspond to high quality of life
Time frame: Whole study period from inclusion to one year after surgery
Quality of life QLQ-OG25 (Range 25- 100). Low values correspond to high quality of life
Time frame: Whole study period from inclusion to one year after surgery
Quality of Life FA-R13 (range 12- 48). Low values correspond to high quality of life
Time frame: Whole study period from inclusion to one year after surgery
Quality of recovery according to Allvin et al. 19 statements which are rated on a four grade scale fron no problem to major problem
Time frame: Whole study period from inclusion to one year after surgery
Disease specific questionnaire, 8 statements rated on a visual analogue scale from 0 (no problem) to 10 (worst imaginable problem). Sum score are used for analysis (Range 0-80)
Time frame: From inclusion (during preoperative information 1-14 days before surgery) to the first postoperative day after the operation
Vital capacity
Time frame: From the day before surgery to discharge from the hospital (app 7-14 days)
Length of stay at the hospital
Göteborg University
Other
Effekt av Prehabilitering Och Extra Tidig Mobilisering Efter öppen Pankreas Kirurgi
Acronym: PreMob
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03410030
Digestive System Diseases, Digestive System Neoplasms
Scottsdale, Arizona, United States
View Trial DetailsNCT02905578
Adenocarcinoma, Cancer of Pancreas
Iowa City, Iowa, United States
View Trial DetailsNCT04263948
Behavior, Digestive System Diseases
Évry, IDF, France
View Trial DetailsNCT04774198
Digestive System Diseases, Digestive System Neoplasms
Copenhagen, Denmark
View Trial Details